School of Medicine
Showing 291-300 of 904 Results
-
Sukmook Lee
Visiting Professor, Neurosurgery
BioProfessor Sukmook Lee, Ph.D., is a distinguished expert in the field of antibody engineering and therapeutic antibody development. He currently serves as the Director of the Antibody Research Institute and Professor in the Department of Biopharmaceutical Chemistry at Kookmin University. Additionally, he holds a Visiting Professorship in the Department of Neurosurgery at Stanford University School of Medicine. His cutting-edge research is globally recognized, particularly for its focus on immunological disorders, infectious diseases, and cancer therapies.
As the head of the Innovative Antibodies Laboratory (InnoAbs), a globally leading research group, Professor Lee spearheads pioneering efforts to develop novel therapeutic antibodies. His lab’s work has made significant strides in cancer immunotherapy, COVID-19 treatment, and the creation of diagnostic antibodies for COVID-19. The InnoAbs Lab also collaborates extensively with academic and industrial partners to drive innovation in therapeutic targeting, cancer progression, and metastasis.
Professor Lee is widely recognized in the scientific community, serving on the editorial boards of high-impact journals such as Scientific Reports, Antibodies, and Frontiers in Bioscience. He also contributes as a bio-advisory board member for leading pharmaceutical companies, including Samsung Biologics, Samsung Bioepis, ISU Abxis, and Ankook Pharmaceutical. His extensive consulting work for both international and domestic industries highlights his pivotal role in bridging academic research with practical medical applications. In addition, he serves as a steering committee member for the Korean Society for Biochemistry and Molecular Biology (KSBMB) and the Antibody Society of Korea (ASK), and is an active member of The Antibody Society and the American Association for Cancer Research (AACR) in the USA.
A visionary researcher, Professor Lee continues to push the boundaries of modern medicine, particularly through his efforts to commercialize groundbreaking antibody platforms for cancer and viral therapies, bringing new hope to patients worldwide. -
Tien-Ching Lee
Affiliate, Orthopaedic Surgery
Visiting Scholar, Orthopaedic SurgeryBioI am an orthopedic surgeon and assistant professor at Kaohsiung Medical University (KMU), serving in the Department of Orthopaedics at Kaohsiung Medical University Hospital, Taiwan. I completed my Ph.D. at KMU in 2023, focusing on orthopedic research and innovation.
My clinical expertise and research interests encompass orthopedic trauma, hand surgery, osteoporosis, and fracture repair. My work has been recognized with several prestigious awards, including the 2018 Merit Paper Award from the Taiwanese Osteoporosis Association and the 2019 AOTAP Scientific Congress Merit Paper Award.
As part of a dynamic research team, I have contributed to significant medical device innovations. Our developments include a novel targeting device for screw positioning and an advanced surgical tool for carpal tunnel release. These innovations have secured patents across multiple jurisdictions, including the United States, Taiwan, China, European nations, and Singapore. Our achievements have been honored with the Taiwan National Innovation Award for four consecutive years (2019, 2020, 2022, and 2024).
Currently, I am a visiting scholar in Dr. Yang's laboratory at Stanford University, where I am expanding my expertise in innovation, research, and development while fostering international collaborations. This aligns with my commitment to advancing orthopedic care through global knowledge exchange and professional networking.
